ATRION Price To Sales Ratio Over Time
| ATRI Stock | USD 459.25 1.00 0.22% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ATRION Performance and ATRION Correlation. ATRION |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATRION. If investors know ATRION will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATRION listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.20) | Dividend Share 8.75 | Earnings Share 10.63 | Revenue Per Share 100.35 | Quarterly Revenue Growth 0.184 |
The market value of ATRION is measured differently than its book value, which is the value of ATRION that is recorded on the company's balance sheet. Investors also form their own opinion of ATRION's value that differs from its market value or its book value, called intrinsic value, which is ATRION's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATRION's market value can be influenced by many factors that don't directly affect ATRION's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATRION's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATRION is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATRION's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare ATRION and related stocks such as Milestone Scientific, InfuSystems Holdings, and Repro Med Systems Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MLSS | 73.6434 | 0.6521 | 2.6961 | 2.9083 | 4.4659 | 5.2065 | 3.6018 | 3.4235 | 1.2165 | 7.5919 | 24.5879 | 13.7597 | 3.8487 | 5.109 | 8.51 |
| INFU | 11.538 | 0.621 | 0.5424 | 0.7514 | 1.0496 | 0.9385 | 0.8031 | 0.7358 | 1.0974 | 2.075 | 3.8774 | 3.4132 | 1.6307 | 1.7617 | 2.2 |
| KRMD | 2.0153 | 0.974 | 0.974 | 0.8851 | 1.3387 | 1.3078 | 1.3078 | 3.6252 | 3.6252 | 10.9323 | 10.4406 | 5.6685 | 5.7591 | 3.9337 | 2.26 |
| NXGL | 9.1027 | 9.1027 | 9.1027 | 9.1027 | 9.1027 | 9.1027 | 9.1027 | 9.8338 | 8.8518 | 66.6227 | 545 | 9.3769 | 3.4026 | 2.9545 | 2.81 |
| DXR | 15.5405 | 30.0596 | (14.7971) | (2.4171) | (6.4683) | (3.9236) | 17.059 | (16.3285) | (33.4085) | (306) | (49.3815) | 7.8255 | 5.9282 | 1.2853 | 1.22 |
| LMAT | 3.5372 | 1.5864 | 1.5372 | 1.9007 | 1.7877 | 3.9109 | 5.2541 | 5.9853 | 4.3501 | 6.0758 | 6.3383 | 6.8818 | 6.256 | 6.5175 | 6.84 |
| UTMD | 1.2061 | 2.5895 | 3.2199 | 5.3278 | 5.49 | 5.4982 | 6.944 | 7.3078 | 7.3786 | 8.56 | 7.3111 | 7.4347 | 6.9935 | 6.0854 | 3.45 |
| MMSI | 8.3333 | 1.4549 | 1.4868 | 1.4935 | 1.4669 | 1.51 | 1.9489 | 2.8967 | 3.3045 | 1.7283 | 3.1925 | 3.2546 | 3.4854 | 3.4906 | 2.66 |
ATRION and related stocks such as Milestone Scientific, InfuSystems Holdings, and Repro Med Systems Price To Sales Ratio description
Price to Sales Ratio is figured by comparing ATRION stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on ATRION sales, a figure that is much harder to manipulate than other ATRION multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| ATRION | ATRI |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Texas; U.S.A |
| Exchange | NASDAQ Exchange |
USD 459.25
Additional Information and Resources on Investing in ATRION Stock
When determining whether ATRION offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ATRION's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atrion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atrion Stock:Check out ATRION Performance and ATRION Correlation. For more detail on how to invest in ATRION Stock please use our How to Invest in ATRION guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
ATRION technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.